Description: The presenters will dig into the little rider that most actuaries don't spend much time thinking about. A regulator, a direct writer and a consultant will discuss their thoughts on this rider and point out areas where actuaries should focus before deeming it insignificant. Topics will include the current study underway to update the industry experience study (most recently done in 1952), underwriting considerations, interactions with other riders, benefit designs, unique issues on UL policies, tax implications and reserving considerations

Description: This session at the SOA 1990 San Francisco Spring Meeting focuses on AIDS including an update on the epidemic and discussion about the actuarial implication of four case studies.

Description: 1998 Valuation Actuary Symposium. This session about strengthening reserves based on cash-flow testing provided some practical solutions to reserve-strengthening issues using reinsurance and a look at the issue from a small company perspective.

Description: This presentation is a concurrent session from the 1991 Meeting of the Society of Actuaries, held April 18-19 in New Orleans. The panelists discuss level term insurance, preferred risk underwriting, and the impact of proposed NAIC Actuarial Guideline XXX on statutory reserves. Discussion from participants is included. From the Record of Society of Actuaries, Volume 17, No. 1.

Description: This session from the 2003 SOA Orlando Meeting covers XXX reserves for term insurance and UL from the ceding company and reinsurer standpoint, X-factor classes, the 2001 CSO and securitization and accessing capital markets for solutions for reserves and capital requirments of XXX. From the Record of the Society of Actuaries, Volume 29, No. 3.

Description: Panelists at this session of the SOA 1991 Toronto Spring Meeting give an overview of Regulation XXX including its effect on product design, proposed actuarial guidelines, 2001 CSO, X-factor analysis and reinsurance issues.

Description: In-depth discussion about HIV and AIDS: [1] mortality-study results, [2] risk-classification challenges, including regulatory issues, [3] mortality-projection methods, [4] significant pricing and valuation – STAT and GAAP – information, and [5] overall industry implications. From the 1988 Record of Society of Actuaries, Vol. 14, No. 4A.

Description: Regulators observed a wide range of practice from early adopters of PBR in regard to the treatment of non-guaranteed reinsurance and adopted a formulaic solution on an interim basis for the 2020 Valuation Manual. A field test, supplemented with additional analysis performed using a model-office approach with representative models, is being performed over the first half of 2020 to inform regulators as they select a longer-term solution. This session will provide an update on this important issue as well as perspectives on how the resolution of this issue was approached and lessons learned for the future from those intimately involved in this work.

Description: Discusses professional statutory valuation standards, provides an update on the proposal of the National Association of Insurance Commissioners' Life and Health Actuarial Task Force [LHATF], and discusses minimum state requirements and federal income tax deductibility for reserves. From the 1987 Record of Society of Actuaries, Vol. 13, No. 1.

Description: From a session at the 2000 Valuation Actuary Symposium held in Washington DC, September 14-15, 2000 The National Association of Insurance Commissioners NAIC Valuation of Life Insurance Policies Model Regulation XXX sets forth the valuation requirements for life insurance with nonlevel premiums or nonlevel benefits, including term insurance and universal life with certain underlying guarantees. Panelists discussed the issues around implementation of the requirements. The issues discussed include: • Determination of X factors when no credible company mortality exists • Proper treatment of secondary guarantees in universal life insurance • Preparation of the mortality assumption opinion requirements • Impacts on product development and design